Drug-supplement interactions on intestinal absorption and its genetic individual variations - Drug-supplement interactions on intestinal absorption and its genetic individual variations

APDD0 个研究点目标入组 16 人开始时间: 2010年12月10日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•the investigors must ensure that all subjects being considerd meet the following exclusion criteria or conditions 1) blood disorder and impairment of liver and kidney function 2) history of asthma 3) porphyria patient 4) deficiency of glucose-6-phosphdehydrogenase 5) impairment of liver or kidney functions 6) grapefruit, orange and apple juice intake within 7 days prior to test drug administration 7) regular use of St. John's Wort 8) recent (past 4 months) participation in other clinical trial using new chemical entity 9) donation of 400mL or more of blood within 3 months prior to participation, donation of 200mL or more of blood within 1 month prior to participation, or donation of component blood within 2 weeks prior to participation 10) positive serologic reaction of syphilis, positive result of HIV test, HBsAg and HCVAb 11) history of multiple and recurring allergies to medicines or food 12) history of drug or alcohol abuse and capable to refrain from alcohol for the designated term 13) the investigator determines this trial participation inadequate by the information at the screening visit 14) vulnerable to alcohol or incapable to intake alcohol 15) the investigator determines this trial participation inadequate

发起方